ABBV-552 in patients with mild Alzheimer's disease: a randomized phase IIb trial.
Saved in:
| Title: | ABBV-552 in patients with mild Alzheimer's disease: a randomized phase IIb trial. |
|---|---|
| Authors: | Lynch SY; Clinical Development, AbbVie Inc., North Chicago, Illinois, USA., Jia J; Statistics, AbbVie Inc, North Chicago, Illinois, USA., Miles N; Clinical Pharmacology, AbbVie Inc, North Chicago, Illinois, USA., Boiser J; Pharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, Illinois, USA., Buhl DL; Precision Medicine, AbbVie Inc, North Chicago, Illinois, USA., Graff O; Clinical Development, AbbVie Inc., North Chicago, Illinois, USA., Zadikoff C; Clinical Development, AbbVie Inc., North Chicago, Illinois, USA. |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2025 Dec; Vol. 21 (12), pp. e70994. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
